Tamoxifen added to radiotherapy and surgery for the treatment of ductal carcinoma in situ of the breast: A meta-analysis of 2 randomized trials

Radiotherapy and Oncology

Volumn 100, Issue 2, 2011, Pages 195-199

  Petrelli, Fausto ^a   Barni, Sandro ^a  

^a TREVIGLIO HOSPITAL   (Italy)

Author keywords

Breast cancer; Ductal carcinoma in situ; Radiotherapy; Tamoxifen

Indexed keywords

TAMOXIFEN;

ADD ON THERAPY; ARTICLE; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RELAPSE; CANCER SURGERY; CANCER SURVIVAL; HUMAN; INTRADUCTAL CARCINOMA; META ANALYSIS; MORTALITY; PRIORITY JOURNAL; SYSTEMATIC REVIEW;

BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; COMBINED MODALITY THERAPY; ESTROGEN ANTAGONISTS; FEMALE; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TAMOXIFEN;

EID: 80052297510     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2011.02.005     Document Type: Article

References (13)

1. B. Fisher, S. Land, E. Mamounas, J. Dignam, E.R. Fisher, and N. Wolmark Prevention of invasive breast cancer in women with ductal carcinoma in situ: an update of the national surgical adjuvant breast and bowel project experience Semin Oncol 28 2001 400 418 (Pubitemid 32762083)
2. B. Fisher, J. Dignam, and N. Wolmark Tamoxifen in treatment of intraductal breast cancer: national surgical adjuvant breast and bowel project B-24 randomised controlled trial Lancet 353 1999 1993 2000 (Pubitemid 29271743)
3. EORTC Breast Cancer Cooperative Group EORTC Radiotherapy Group N. Bijker, P. Meijnen, and J.L. Peterse Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: ten-year results of European organisation for research and treatment of cancer randomized phase III trial 10853 - a study by the EORTC breast cancer cooperative group and EORTC radiotherapy group J Clin Oncol 20;24 2006 3381 3387 (Pubitemid 46638893)
4. J. Houghton, W.D. George, J. Cuzick, C. Duggan, I.S. Fentiman, M. Spittle UK Coordinating Committee on Cancer Research Ductal Carcinoma in situ Working Party DCIS trialists in the UK, Australia, and New Zealand Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ of the breast in the UK, Australia, and New Zealand: randomised controlled trial Lancet 362 2003 95 102 (Pubitemid 36831018)
5. J. Cuzick, I. Sestak, and S.E. Pinder Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK/ANZ DCIS trial Lancet Oncol 12 2011 21 29
6. L. Holmberg, H. Garmo, and B. Granstrand Absolute risk reductions for local recurrence after postoperative radiotherapy after sector resection for ductal carcinoma in situ of the breast J Clin Oncol 26 2008 1247 1252
7. R. DerSimonian, and N. Laird Meta-analysis in clinical trials Control Clin Trials 7 1986 177 188 (Pubitemid 17189972)
8. J. Lau, J.P. Ioannidis, and C.H. Schmid Quantitative synthesis in systematic reviews Ann Intern Med 127 1997 820 826 (Pubitemid 27465551)
9. B. Fisher, J.P. Costantino, and D.L. Wickerham Tamoxifen for prevention of breast cancer: report of the national surgical adjuvant breast and bowel project P-1 study J Natl Cancer Inst 90 1998 1371 1388 (Pubitemid 28439961)
10. C.I. Li, J.R. Daling, P.L. Porter, M.T. Tang, and K.E. Malone Adjuvant hormonal therapy for breast cancer and risk of hormone receptor-specific subtypes of contralateral breast cancer Cancer Res 69 2009 6865 6870 Erratum in: Cancer Res 2010 Jan 15; 70: 853. Cancer Res 2010 Mar 1; 70: 2140
11. C. Chargari, R.A. Toillon, D. Macdermed, P. Castadot, and N. Magné Concurrent hormone and radiation therapy in patients with breast cancer: what is the rationale? Lancet Oncol 10 2009 53 60
12. L.L. Hughes, M. Wang, and D.L. Page Local excision alone without irradiation for ductal carcinomain situ of the breast: a trial of the Eastern cooperative oncology group J Clin Oncol 27 2009 5319 5324
13. Hughes KS, Schnaper LA, Cirrincione C et al. Lumpectomy plus tamoxifen with or without irradiation in women age 70 or older with early breast cancer. Program and abstracts of the 2010 Annual Meeting of the American Society of Clinical Oncology; June 4-8, 2010; Chicago, Illinois, Abstract 507.